The report examines registration and pricing practices for specific products and countries. A key finding is more companies are making progress in setting prices reflecting the socioeconomic context, with greater use of equitable pricing strategies.
Yet performance of the pharmaceutical industry continues to lag in some areas critical to improving access. For example, whilst companies are refining their pricing strategies to improve affordability of more products, they are applying them in few countries.
The Index highlights the significant potential for the industry to make medicines more accessible.
New malaria technologies are tackling the problem of insecticide resistance in mosquitos. Dr. Tom McLean from IVCC discusses how to get these new tools to the people who need them.
Through the Global Access Initiative, we are helping to increase access viral load testing through the Panther platform. Ahead of World AIDS Day 2020, two laboratory technicians in Kenya and Zambia told us how Panther is helping them to better serve patients.
Michael joined an ODI panel to assess the immediate development finance institutions' (DFI) response to the COVID-19 pandemic and how DFI’s could support public sector investment in the health sector.